SOURCE: Wall Street News Alert

March 16, 2006 09:47 ET

Stock Alert: Emerging Public Company Targets Self Insured Corporate Healthcare Companies! March 16, 2006

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Wall Street Capital Funding.

WESTON, FL -- (MARKET WIRE) -- March 16, 2006 -- Wall Street News Alert's "stocks to watch" this morning are: Imagin Molecular Corporation (OTC BB: IMGM), TSMC (NYSE: TSM), Walgreen Co (NYSE: WAG), and Wyeth (NYSE: WYE).

Imagin Molecular Corporation (OTC BB: IMGM) may be a target of aggressive investors and day traders this morning! Early this morning, the company issued a press release announcing the identification of additional markets to benefit their coronary disease reversal and prevention centers.

The news of should get the attention of investors! Imagin it set to release a landmark report that will demonstrate a 25% or greater reduction of total coronary disease management costs. The report will further show direct and indirect financial benefits for corporations who choose to self-insure. Imagin intends to offer full outsourced solutions to large self insurers such as unions, federal and local government agencies and large corporations such as General Motors, Wal-Mart, etc.

Continue to watch this company! Imagin's solution and approach represents the inevitable shift from traditional methods of coronary disease management to less invasive imaging followed by non-surgical therapies. Imagin, through its Coronary Disease Reversal and Prevention Centers, is positioned to be the first company to offer such techniques to larger companies as a solution to their largest expenditure of healthcare dollars.

Investors should continue to monitor the progress of Imagin Molecular! Joseph Oliverio, CEO of Imagin, states, "Imagin's access to data and execution model will position Imagin to be the logical choice of coronary disease management contracts from self-insured large corporations. Imagin will be the first to demonstrate benefits with real patient data that will prove substantial patient and economic improvements much greater than the current practice. In the past, studies have only demonstrated theory through econometric data without the clinical applications and results that Imagin possess. With cooperation from Positron Corporation, we will be able to deliver affordable PET and PET / CT devices for widespread distribution to Imagin supported centers markets. In addition Positron Corporation is currently implementing innovative software solutions specific to the coronary disease reversal and prevention market further positioning them to be the market leader in the industry."

The stock closed yesterday at Thirty-Nine cents a share.

To view all of Wall Street News Alert's special early morning trading alerts for this morning, visit www.WallStreetNewsAlert.com, where you may also sign up to receive free email alerts in advance of our press releases being issued.

In case you are not familiar with the company: Imagin Molecular Corporation strategy and focus is dedicated to business opportunities in positron emission tomography (PET) manufacturing and the diagnosis of cancer, heart disease and neurological diseases. PET is an advanced medical diagnostic imaging procedure used by physicians in the detection of certain cancers, coronary disease and neurological disorders including Alzheimer's disease. Imagin Molecular Corporation has positioned the Company to be a factor in PET and ancillary molecular imaging businesses. Imagin Nuclear Partners, a wholly owned subsidiary of Imagin Molecular Corporation, is a full-service joint venture molecular imaging partner that will own, operate and administer out-patient medical diagnostic imaging centers that utilizes PET and PET/CT scanning equipment. Imagin Nuclear Partners specializes in using evidence-based bioinformatics specifically positioned in the market to provide the maximal cost effective benefit to their joint venture partner and the community. Imagin Molecular Corporation is also the parent of Cipher Multimedia, Inc., a new media marketing and distribution solution company that provides a Distribution Solution for publishers of digital content.

TSMC (NYSE: TSM) up 1.7% on 8.2 million shares traded.

TSMC is a dedicated semiconductor foundry, providing the industry's leading process technology and the foundry industry's largest portfolio of process-proven library, IP, design tools and reference flows.

Walgreen Co (NYSE, NASDAQ: WAG) down 1.6% on 2.8 million shares traded.

Walgreen Co. is one of the nation's largest drugstore chains.

Wyeth (NYSE: WYE) up 0.5% on 2.8 million shares traded.

Wyeth is one of the world's largest research-driven pharmaceutical and health care products companies.

Commentary:

"GE is buying Zenon Environmental Inc., of Ontario, Canada for $655 million. This is General Electric's second purchase of a water filtration company in the past year. Zenons products are used to filter water for municipal and agriculture use. Last year GE bought a similar company called Ionics Inc, a desalination company. Clean water daily is available to only 50% of the worlds population and is some areas is a cherished commodity," stated Sonja Rudd in Wall Street News Alert's daily commentary continued at: http://www.WallStreetNewsAlert.com.

Let Wall Street News Alert help advertise for your company using our effective awareness campaigns. If you're Interested in telling your story, we can help. Contact us at info@wallstreetnewsalert.com

WSNA's email alert service is free to those investors who sign up on the WSNA home page. The alert service is designed to notify investors of undervalued and often overlooked stocks. Subscribers are introduced to Special Situation companies that have the potential of showing increased activity. The Wall Street News Alert home page has experienced over 50 million hits. To subscribe to this free service, visit the Wall Street News Alert home page at http://www.wallstreetnewsalert.com and select the "join now" button.

*** Wall Street News Alert is not affiliated with faxes bearing names such as: Wall Street Stock Alert, Wall Street Investor Alert, Wall Street News Alert or any other fax using various combinations of the generic words Wall Street! If you receive any such fax, please do not contact us at www.wallstreetnewsalert.com. You may wish to inquire about the fax, with the CEO of the company that the fax is written about ***

Wall Street News Alert is a division of Wall Street Capital Funding LLC (WSCF). WSCF is not a registered broker/dealer and may not sell, offer to sell or offer to buy any security. WSCF profiles are not a solicitation or recommendation to buy, sell or hold securities. An offer to buy or sell can be made only with accompanying disclosure documents from the company offering or selling securities and only in the states and provinces for which they are approved. The material in this release is intended to be strictly informational. The companies that are discussed in this release have not approved the statements made in this release nor approved the timing of this release. All statements and expressions are the sole opinion of WSCF and are subject to change without notice. Information in this release is derived from a variety of sources including that company's publicly disseminated information, third parties and WSCF research. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. WSCF disclaims any and all liability as to the completeness or accuracy of the information contained and any omissions of material fact in this release. The release may contain technical inaccuracies or typographical errors. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. Investment in the securities of the companies discussed in this release is highly speculative and carries a high degree of risk. WSCF is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment if they make a purchase in WSCF profiled stocks.

This profile is not without bias, and is a paid release. WSCF has been compensated for dissemination of company information on behalf of one or more of the companies mentioned in this release. WSCF has been compensated Five Thousand Dollars for coverage of Imagin Molecular Corporation (OTC BB: IMGM), by a third party (CLX & Associates Inc.), who is non-affiliated and may hold a significant position in the stock, for services provided including dissemination of company information in this release. WSCF holds no shares of the stock. WSCF may receive additional compensation for extension of its services. Any additional compensation will be disclosed at such time that WSCF is aware of a client's desire to extend the original services. WSCF may have received shares of a company profiled in this release prior to the dissemination of the information in this release. WSCF may immediately sell some or any shares in a profiled company held by WSCF and may have previously sold shares in a profiled company held by WSCF. WSCF's services for a company may cause the company's stock price to increase, in which event WSCF would make a profit when it sells its stock in a company. In addition, WSCF's selling of a company's stock may have a negative effect on the market price of the stock.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may," "future," "plan" or "planned," "will" or "should," "expected," "anticipates," "draft," "eventually" or "projected." You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and WSCF undertakes no obligation to update such statements.

Contact Information